wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Carragher who wrote (556)	2/20/1999 10:33:00 PM
From: Anthony Wong	of 942

There are several clinical trials aimed at treating neuropathic diseases of the nervous system for which there are currently no approved treatments, such as shingles, phantom limb pain, and the searing pain in the extremities that affects diabetics. Myelos Neurosciences Corp. in San Diego is in the second phase of testing Prosaptide TX14(a), a drug that regenerates the damaged nerves that cause the neuropathy. And there is increasing interest in Warner-Lambert Co.'s epilepsy drug, Neurontin, introduced five years ago, because the nerve centers that control seizures and those that control pain are closely linked. Two new studies report that Neurontin is highly effective in the treatment of diabetic neuropathy and shingles. Conquering Pain, New discoveries and treatments offer hope Message 7939820

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next